Among patients with Merkel cell carcinoma, using ctDNA testing may help with watching the disease for potential recurrences ...

More than 60% of patients with relapsed or refractory KMT2Ar acute leukemia responded to the menin inhibitor revumenib.

CURE partnered with SHARE Cancer Support to learn more about the importance of emotional well-being and a strong support ...

Cancer is complicated, especially with multiple diagnoses, oncologists, tests and integrative treatments, but AI can be a ...

Lazcluze demonstrated significant CNS activity, regardless of T790M status, in treating intracranial and leptomeningeal ...

This trial is assessing CBX-12 as a potential treatment for ovarian cancer, with additional studies to be conducted in other ...

For patients with adenocarcinoma of the esophagus and esophagogastric junction, chemoradiotherapy and chemotherapy improved ...